Nucleofector™ PLUS Supplements
These specialized supplements which are used instead of the standard kit supplement allow cryopreservation of freshly isolated or harvested cells in Nucleofector™ Solution.
“By decoupling cell harvesting and transfection, Nucleofection™ Experiments can be done at the scientist’s convenience. Cells can be collected, stored and are ready-to-use at a later time, and deliver transfection results comparable to fresh cells. Larger cell batches can be cryopreserved so that researchers can avoid batch-to-batch variances in transfection results. Thus, Nucleofector™ PLUS Supplements can make whole experimental programs more consistent.” explains Dr. Herbert Mueller-Hartmann, Head of R&D Discovery Technologies.
Nucleofection™ is a transfection technology that was first introduced into the market in 2001. It is based on the unique combination of electrical parameters and cell-type specific solutions. It is known as the first efficient non-viral transfection method for primary neural cells and has been stated in over 300 peer-reviewed publications as the method of choice for transfection of primary neurons.
For further Information:
Lonza Cologne GmbH
Marketing Communication and Product PR
Phone: +49 221 99199 464
Lonza Group Ltd
Phone: +1 201 316 9413